Finding accredited CPD
Lung cancer is the second most common cancer in the world, accounting for 11.4% of all cancers, but with 18.0% of total cancer-related deaths, it is the leading cause of cancer death.
In Australasia, the incidence of lung cancer varies between 19.1 and 42.1 per 100,000 population, with the strongest risk factors historically being increasing age and tobacco smoke exposure.
While tobacco control remains the mainstay of reducing the impact of lung cancer for decades to come, there have been recent highly significant advances in lung cancer diagnostic approaches and treatment regimens which are beginning to affect outcomes for Australians with lung cancer.
This MJA perspective shares more.
Authors: Fraser J Brims, Annette McWilliams, Susan V Harden and Ken O'Byrne
Article Type: Perspective
You have to log in to see the content of this module.
Provided by
Accredited by
*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)